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MORPHEA AND LICHEN SCLEROSUS  
IN A PATIENT WITH HYPORTHYROIDISM
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SUMMARY – Thyroid gland is one of the key organs regulating the metabolism of carbohydrates, 
proteins and fats. Its primary function is connected with increase of the metabolic conversion of the 
body. Skin lesions are often one of the first symptoms of hypothyroidism. In a 71-year-old patient, 
skin lesions in the form of thickened areas with severe hyperkeratosis first appeared 12 years before. 
Eight years before, the patient was diagnosed with hypothyroidism of unknown cause. Upon admis-
sion, lesions were observed in the trunk area, left arm and vulva. These lesions had the appearance of 
brownish spots with hyperkeratosis. Initially, they were localized on the trunk, then involving upper 
limbs and neck area with time. Significant progression was present in the back area. In the anogenital 
area, porcelain-white discolorations were observed. Laboratory examinations were normal. During 
hospital stay, iv. ceftriaxone at a dose of 2.0 g/day for 10 days and intramuscular injection of vitamin 
B6 were administered, along with 10% urea ointment for hyperkeratosis lesions as topical therapy. The 
patient had lesions in the form of skin induration and discoloration, with visible, very severe hyper-
keratosis, which is not characteristic of changes of the scleroderma and lichen sclerosus type. These 
lesions caused diagnostic problems due to the atypical clinical appearance.
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Introduction
Thyroid gland is one of the key organs regulating 
the metabolism of carbohydrates, proteins and fats. Its 
primary function is connected with increase of the 
metabolic conversion of the body. Nowadays, the main 
cause of hypothyroidism are autoimmune diseases, 
most commonly Hashimoto’s thyroiditis. Over 90% of 
patients are women. Hypothyroidism can also occur 
during the treatment of hyperthyroidism with radioio-
dine or after surgical removal. Less frequently, it is 
 observed in endemic areas of iodine deficiency1.
Typical systemic symptoms of hypothyroidism in-
clude weight gain, excessive tiredness, feeling of cold, 
and constipation. Skin lesions are often one of the 
first symptoms of the disease. The skin has a tendency 
to edema and dryness. A lack of facial expressions is 
frequently observed. Spilled swellings are most often 
connected with mucin deposition and they lead to 
myxedema. Hair is dry and tends to fall out. A typical 
symptom is also loss of the lateral one-third of eye-
brows. Nails also grow slowly and are fragile. The 
tongue is enlarged and can interfere with speech. The 
whole skin can have a yellowish color, connected with 
a disorder of carotenoid metabolism. Within its reach, 
there may also be hyperkeratotic areas1-3.
Morphea and lichen sclerosus are known to be as-
sociated with an increased incidence of autoimmune 
disorders and autoantibodies, so the coexistence of 
other autoimmune diseases is expected. Localized 
scleroderma (morphea) and lichen sclerosus are the 
connective tissue diseases associated with sclerosis of 
the skin. They often appear in the same patient. Both 
may be localized or generalized. The etiology and pre-
cise mechanisms that trigger the cascade of molecular 
events that culminate in skin fibrosis are not clearly 
understood. Many inflammatory and immune path-
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ways are ultimately responsible for vascular changes, 
increased collagen production, and extracellular matrix 
proliferation.
There are many clinical subtypes of localized 
scleroderma, which include plaque profundus, bullous, 
linear, frontoparietal, segmental, and guttate types. 
Plaque type morphea is the commonest subtype4.
Morphea and lichen sclerosus are immune diseases 
that may be associated with other autoimmune disor-
ders. The coexistence of two autoimmune diseases may 
not occur by chance, but could be attributed to auto-
immune reactions elicited by recognition of common 
antigens4-7. 
We present a case of a patient diagnosed with hy-
pothyroidism, who had lesions in the form of thick-
ened areas and skin hyperpigmentation, with visible 
hyperkeratosis diagnosed as localized scleroderma, 
which posed diagnostic problems due to atypical clini-
cal presentation.
Case Report
A 71-year-old female patient reported the first skin 
lesions in the form of thickened areas with severe hy-
perkeratosis to have appeared 12 years before. Initially, 
they were localized on the trunk, then also involved 
upper limbs and neck area with time. Simultaneously, 
the patient complained of weight gain, feeling of cold 
and generalized dryness of the skin, but systemic 
symptoms were not diagnosed. In 2004, lesions in the 
form of porcelain-white discoloration spots appeared 
in the vulva area. Eight years before, the patient was 
diagnosed with hypothyroidism of unknown cause. 
Since that time, the patient was under endocrinologi-
cal care. Currently, euthyroidism was achieved. In the 
meantime, due to progression of skin lesions, the pa-
tient was hospitalized several times at the Department 
of Dermatology. Procaine penicillin, cefuroxime, Pias-
cledine®, vitamin E and psoralen and ultraviolet A 
(PUVA) light therapy were used in the treatment. Due 
to the ambiguous clinical presentation of skin lesions, 
several skin biopsies were obtained for histopathologic 
examination. In 2006, the finding in specimens ob-
tained from the trunk and left arm corresponded to 
‘morphea’, while the one obtained from vulva was in-
dicative of lichen sclerosus. In 2014, the patient was 
admitted to the Department of Dermatology, Silesian 
Medical University because of the significant progres-
sion of skin lesions and hyperkeratosis accompanied by 
severe itch.
At admission, lesions were observed in the trunk, 
left arm and vulva areas. The lesions had the appear-
ance of brownish spots with hyperkeratosis. Signifi-
cant progression was observed in the back area. In the 
anogenital area, porcelain-white discolorations were 
observed. Peripheral lymph nodes were not enlarged. 
Mucous membranes and nail plates were free of le-
sions (Figs. 1 and 2).
Laboratory tests: erythrocyte sedimentation rate, 
morphology with peripheral blood smear, iron level, 
electrolytes, AspAT, ALAT, GGTP, bilirubin, creati-
nine, urea, protein, protein electrophoresis, CPK, al-
dolase, triglycerides, cholesterol, joint reactions (La-
tex-R, Waaler-Rose test, ASO), urinalysis and glucose 
levels were normal. Chest radiograph was without ab-
Fig. 1. Typical hyperkeratotic changes on the back.
Fig. 2. Porcelain-white discolorations on the abdomen.
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normalities. Esophagography indicated disturbed swal-
lowing partially, with flabby esophagus, slightly wid-
ened in the middle and lower segments (with weak-
ened peristalsis), and medium contrast retention. Ab-
dominal ultrasound revealed increased fatty liver with 
a small cyst in the right lobe, cysts of about 30 mm in 
both renal pelvis, small cortical cysts, and signs of lipo-
fibromatosis. Mycologic diagnostics (microscopic ex-
amination and culture, swabs taken from the back 
area) proved negative. Capillaroscopy showed no ab-
normalities. Histopathologic examination (back area) 
showed atrophic epidermis with excessive and partial 
keratosis, with the formation of subepidermal blisters. 
In the dermis, edema and unification of the structure 
with hyperplasia of capillary vessels and perivascular 
lymphocyte infiltrations were observed. Microscopic 
image was quite ambiguous. The results were typical 
for lichen sclerosus and morphea. ANA2 antibodies 
were not detected by indirect immunofluorescence on 
Hep2 cells. IgG and lgM antibodies against Borrelia 
burgdorferi were negative.
During stay at the Department, the patient was 
 administered iv. ceftriaxone at a dose of 2.0 g per day 
for 10 days and intramuscular injections of vitamin B6, 
along with 10% urea ointment for hyperkeratosis le-
sions as topical treatment. When improvement was 
achieved, the patient was discharged and referred to 
Dermatologic Outpatient Clinic. Now, the patient is 
under outpatient care. Skin changes are less pigmented 
and the skin is more elastic.
A written informed consent was obtained from the 
patient for publication of this case report and any ac-
companying images.
Discussion
The main function of the thyroid gland is control-
ling metabolic processes in the body. Disorders of its 
functions cause multi-organ changes, of which skin le-
sions are some of the most noticeable. Hypothyroidism 
is mainly caused by autoimmune disorders, the most 
common of these being Hashimoto’s thyroiditis. It can 
also occur after treatment of hyperthyroidism or in en-
demic regions with iodine deficiency1. In some cases, it 
is not possible to determine the cause of the disease; in 
such a situation, the patient is managed as described in 
this paper. The literature contains reports on many dis-
orders of the skin and subcutaneous tissue, which are 
described as typically coexisting with thyroid diseases4. 
Frisch et al.5 report on vitiligo and alopecia areata as the 
most typical disorders. They examined the connection of 
non-segmental vitiligo with autoimmune thyroid dis-
eases. Their prospective study involved 626 patients with 
vitiligo. The level of antibodies against thyroid peroxi-
dase was determined and was positive in 131 patients. 
The authors also found vitiligo associated with thyroid 
peroxidase antibodies to have different clinical features 
from vitiligo without positive antibodies6.
Kasumagic-Halilovic et al. also investigated coexis-
tence of vitiligo and thyroid disease. The aim of their 
study was to determine the prevalence and significance 
of antinuclear antibodies (ANA) and anti-thyroid per-
oxidase (anti-TPO) antibodies in patients with vitili-
go. In their prospective case-control study, the preva-
lence of ANA and anti-TPO was compared between 
40 patients with these dermatoses and 40 healthy vol-
unteers. ANA was positive in 7 (17%) patients and this 
result was slightly higher than in the control group 
(n=2; 5%). Anti-TPO was positive in 11 (27%) pa-
tients. In the control group, only two (5%) subjects had 
positive anti-TPO result. The results obtained indi-
cated a significant relationship between leukoderma 
and autoimmune thyroid disease8. In contrast, antinu-
clear antibodies have a limited diagnostic value. Thorn-
sberry and English investigated cases of granuloma 
annulare that appeared in the course of both hypo- 
and hyperthyroidism9.
Bjekic et al. tried to determine some risk factors for 
lichen sclerosus in men. Out of 73 patients with lichen 
sclerosus, 9 men had various thyroid gland diseases7. 
Ghayad et al. included 36 scleroderma patients in their 
study and found 7 abnormal cases including 6 cases of 
hypothyroidism secondary to autoimmune thyroiditis 
and one case of hyperthyroidism secondary to Graves’ 
disease. In the hypothyroid subgroup, 3 cases present-
ed localized systemic sclerosis and diffuse systemic 
sclerosis each, while Sjögren’s syndrome was found in 
two of these patients6.
There also are literature reports on coexistence of 
autoimmune thyroid diseases, in particular Basedow-
Graves’ disease, and chronic urticaria10. Chronic urti-
caria is defined as the presence of evanescent wheals 
that persist for more than six weeks. Over half of all 
cases of chronic idiopathic urticaria have autoimmune 
mechanism with autoantibodies of mainly high affin-
ity to the receptor (FcsRI) immunoglobulin E (IgE). 
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This corresponds to the hypothesis on strong relation-
ship between chronic urticaria and autoimmune dis-
eases such as rheumatoid arthritis, thyroid diseases, 
systemic lupus erythematosus (SLE), celiac disease, 
Sjögren’s syndrome and diabetes type 111. Yadav et al. 
report on slightly different results. They also examined 
the relationship between thyroid diseases and chronic 
idiopathic urticaria. According to these authors, the 
presence of thyroid autoantibodies was observed in 
only 5% of patients in this group12. To our knowledge, 
there are no literature reports similar to our case with 
unusual appearance of morphea and lichen sclerosus 
complicated by significant hyperkeratosis. The only lit-
erature report related to such a finding is the one by 
Kreuter et al. who tested 532 patients diagnosed with 
lichen sclerosus. Anti-thyroid antibodies were more 
frequently detected in patients with lichen sclerosus of 
the skin as compared with control group13.
Melcescu et al. tried to estimate the coexistence of 
Graves’ disease, hypoparathyroidism and connective tis-
sue diseases, mainly SLE. However, study results did 
not indicate such a relationship14. Allam and Ghozzi15 
and Berlger-Czop et al.16 presented cases of scleromyx-
edema associated with hypothyroidism. The disease is 
rare and connected with the accumulation of mucin de-
posits, fibroblast proliferation and fibrosis. In patients 
without thyroid disease, coexistence with paraprotein-
emia (mainly IgG, lambda type) is observed.
Systemic changes include gastrointestinal tract, 
skeletal muscle, lungs, cardiovascular system, kidneys 
and central nervous system, and lead to severe compli-
cations. Numerous reports also describe pretibial myx-
edema as typical comorbidity in the course of hyper-
thyroidism.
Lohiya et al. presented a 62-year-old patient with 
Basedow-Graves’ disease without ophthalmopathy, 
but with pretibial myxedema. In addition to skin le-
sions, the patient complained of the symptoms of anx-
iety, insomnia and fatigue lasting for up to 6 months. 
The patient also described chest pain combined with 
palpitation and 25-kg weight loss. Skin lesions were 
accompanied by itching and burning17. Pretibial myx-
edema is an autoimmune manifestation of Basedow-
Graves’ disease. Vannucchi et al. treated pretibial myx-
edema in the course of Basedow-Graves’ disease using 
dexamethasone with lidocaine and saline solution 
passed via mesotherapy ≤4 mm needles into the der-
mis or first layer of subcutaneous fat. The preparation 
was administered once a week for 6 weeks. Improve-
ment of local state and ~15% reduction of lesion thick-
ness on ultrasonography were observed in patients, 
mainly in the dermis18.
Zoabi et al. studied thyroid function in 100 patients 
with psoriasis vulgaris. The following parameters were 
determined: TSH, T3, T4, anti-TPO and anti-thyro-
globulin. In patients with psoriasis, the increase of 
anti-TPO was found in 9 (9%) psoriasis patients as 
compared to 3 (5.6%) patients in control group. The 
increase of anti-TG was observed in 3 (3%) patients 
with psoriasis as compared to one (1.8%) patient in 
control group. The increase of TSH was demonstrated 
in 5 (5%) patients with psoriasis as compared to 3 
(5.6%) patients in control group. T3 levels were abnor-
mal in 3 patients and T4 levels in 2 patients with pso-
riasis, whereas the results in control group patients 
were normal. The study did not find statistically sig-
nificant difference in thyroid function between psoria-
sis patients and control group19.
Kavala et al. studied correlations between the oc-
currence of thyroid diseases and pemphigus vulgaris. 
This study included 80 patients with pemphigus vul-
garis and 80 healthy volunteers. Patients were evalu-
ated for the levels of fT3, fT4, TSH, antibodies, anti-
TPO and anti-thyroglobulin antibodies (Tg). Primary 
thyroid disease was diagnosed on the basis of the fol-
lowing diagnostic criteria: positive antibodies and thy-
roid dysfunction. Significant changes in serum profile 
were recorded in 16% (13/80) of pemphigus vulgaris 
patients and 5% (4/80) of control subjects. Positive 
anti-thyroid antibodies (anti-TPO and anti-Tg) were 
observed in 7 (9%) patients with pemphigus vulgaris 
and one (1.2%) control subject. Hashimoto’s disease 
was diagnosed in 9 patients with pemphigus vulgaris. 
Moreover, this disease was found to be more prevalent 
in the form of pemphigus vulgaris occupying mucous 
membranes. Considering the results obtained, the au-
thors suggested that pemphigus vulgaris could coexist 
with autoimmune thyroid diseases, especially Hashi-
moto’s disease20.
Conclusion
We presented a rare case of a patient diagnosed 
with hypothyroidism. The patient had lesions in the 
form of induration and discoloration of the skin, with 
visible, very severe hyperkeratosis, which is not charac-
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teristic of scleroderma and lichen sclerosus type of le-
sions. These lesions caused diagnostic problems due to 
their atypical clinical appearance. Considering the as-
sociation of autoimmune diseases and thyroid diseases, 
we suggest to perform thyroid screening in all patients 
with morphea and lichen sclerosus.
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Sažetak
MORFEA I SKLEROTIČNI LIHEN KOD BOLESNICE S HIPOTIREOZOM
B. Bergler-Czop i L. Brzezińska-Wcisło
Štitna žlijezda jedan je od ključnih organa koji regulira metabolizam ugljikohidrata, bjelančevina i masti. Njezina glavna 
funkcija povezana je s porastom konverzije u organizmu. Kožne promjene često su jedan od prvih simptoma hipotireoze. Kod 
naše bolesnice u dobi od 71 godine kožne promjene u vidu zadebljanih područja uz tešku hiperkeratozu prvi put su se poja-
vile 12 godina ranije, a osam godina ranije dijagnosticirana joj je hipotireoza nepoznatog uzroka. Kod prijma bolesnice 
opažene su promjene u području trupa, lijeve ruke i vulve. Te promjene izgledale su poput smeđkastih točkica s hiperkerato-
zom. U početku su bile lokalizirane na trupu, da bi kasnije s vremenom zahvatile gornje udove i područje vrata. Značajna 
progresija lezija zabilježena je na leđima. U anogenitalnom području opažene su porculanski bjelkaste mrlje na koži. Labo-
ratorijski testovi bili su normalni. Za vrijeme hospitalizacije bolesnica je primala ceftriakson iv. u dozi od 2,0 g/dan kroz 10 
dana i intramuskularne injekcije vitamina B6, uz lokalnu terapiju kremom s 10% ureje za hiperkeratotične lezije. Bolesnica je 
imala promjene u obliku kožne induracije i diskoloracije, uz vidljivu i vrlo tešku hiperkeratozu, što nije karakteristično za 
promjene tipa sklerodermije i skleroznog lihena. Ove promjene izazvale su dijagnostičke probleme zbog netipičnog kliničkog 
izgleda.
Ključne riječi: Hipotireoza; Koža; Hiperkeratoza
